AccessOne will expand our addressable market by roughly $6 billion and strengthen our ability to help providers improve collections while preserving patient trust.
— Chaim Indig
03Detailed Report
PHR
Company PHR
Period
Q2 2026
CurrencyUSD
Report TypeQuarterly Earnings
GeneratedMay 25, 2026
Swipe to view all report sections
Executive Summary
Phreesia delivered a solid QQ2 2026 performance with healthier top-line growth and a meaningful shift in profitability dynamics, underscored by a first-time positive net income and a robust cash-generating profile. Total revenue reached $117.3 million, up 15% year over year, while profitability improved via elevated operating leverage, with Adjusted EBITDA of $22.0 million and an operating income of $26.1 million (operating margin ~22.3%). The quarter also featured a landmark strategic development: the announcement to acquire AccessOne for $160 million, a move the company asserts will expand addressable markets by about $24 billion (roughly $6 billion for payments and $6 billion for network solutions TAMs, plus broader Life Sciences marketing opportunities). Management projected to update full-year guidance post-close, maintaining a revenue range of $472β$482 million and Adjusted EBITDA of $87β$92 million, while targeting approximately 4,500 AHSCs in fiscal 2026.
Separately, Phreesia is advancing monetization of AI-enabled features, notably Voice AI, which management characterizes as rapidly growing with client feedback to date. The company views AI as a multi-product set that has begun to contribute to revenue and client productivity, with further upside expected as deployments scale across the provider network. These dynamics collectively position Phreesia to sustain growth through a combination of core platform expansion, strategic acquisitions, and AI-enabled monetization, albeit with integration and execution risks associated with the AccessOne closing and the ongoing investments in product development and sales capability.
Key Performance Indicators
Revenue
Increasing
117.26M
QoQ: 1.14% | YoY: 14.83%
Gross Profit
Increasing
121.29M
1.03% margin
QoQ: 55.75% | YoY: 96.23%
Operating Income
Increasing
26.15M
QoQ: 895.41% | YoY: 251.81%
Net Income
Increasing
654.00K
QoQ: 116.71% | YoY: 103.63%
EPS
Increasing
0.01
QoQ: 116.57% | YoY: 103.55%
Revenue Trend
Margin Analysis
Financial Highlights
Revenue: $117.3M, YoY +14.8% (reported YoY growth) | QoQ +1.1%
Adjusted EBITDA: $22.0M, margin ~19%
Net income: $0.654M, YoY +103.6%, QoQ +116.7%
EPS: $0.011, Diluted $0.0106, YoY +103.6%, QoQ +116.6%
AHSCs (average healthcare services clients): 4,467, QoQ +56, YoY +298
Revenue per AHSC: $26,249, YoY +7%
Operating cash flow: $14.84M, YoY +$3.8M
Free cash flow: $13.07M, YoY +$6.0M
Cash and cash equivalents: $98.27M (end of quarter); Net debt: -$93.51M (net cash)
Capital expenditures: $1.77M; Free cash flow yield supported by positive operating leverage
Guidance (FY2026): Revenue $472β$482M; Adjusted EBITDA $87β$92M; AHSCs ~4,500; revenue per AHSC growth expected vs. FY2025
TAM update: AccessOne expansion adds ~$6B TAM in payments and ~$6B in network solutions; combined TAM expansion ~+$24B from ~$10B prior base
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
117.26M
14.83%
1.14%
Gross Profit
121.29M
96.23%
55.75%
Operating Income
26.15M
251.81%
895.41%
Net Income
654.00K
103.63%
116.71%
EPS
0.01
103.55%
116.57%
Key Financial Ratios
Management Insights Available for Members
Get exclusive access to management commentary, earnings call quotes, and forward guidance from company leadership.